aids

The grant is part of a $2.3 million “innovation fund” set aside for programs that could help the state lower costs and improve care

March 12, 2012—A bill that would have required the state to continue paying for drugs used for mental illnesses, HIV/AIDS, cancer, and immunosuppressant drugs until 2016 died in the last days of the Legislature, blocked by the House and facing a veto threat from Governor Kitzhaber.

January 24, 2012 -- Syringe exchange programs are unlikely to suffer major financial impact as a result of a Congressional vote in December that halted federal funding. “It's actually going to have minimal impact,” said Kathy Oliver, executive director of Outside In, which has been operating a needle exchange since 1989. “It's a giant step backward in terms of public policy.”